Recent Finacing
Recent Raise
Sensulin is a biotechnology company developing glucose-responsive insulin using Agglomerated Vesicle Technology, a stimulus-triggered injectable and inhalable drug delivery platform adaptable to multiple therapeutics.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at Sensulin.
